These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 29744893)

  • 1. Genome-wide binding of transcription factor ZEB1 in triple-negative breast cancer cells.
    Maturi V; Enroth S; Heldin CH; Moustakas A
    J Cell Physiol; 2018 Oct; 233(10):7113-7127. PubMed ID: 29744893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dual regulation by microRNA-200b-3p and microRNA-200b-5p in the inhibition of epithelial-to-mesenchymal transition in triple-negative breast cancer.
    Rhodes LV; Martin EC; Segar HC; Miller DF; Buechlein A; Rusch DB; Nephew KP; Burow ME; Collins-Burow BM
    Oncotarget; 2015 Jun; 6(18):16638-52. PubMed ID: 26062653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intratumoral bidirectional transitions between epithelial and mesenchymal cells in triple-negative breast cancer.
    Yamamoto M; Sakane K; Tominaga K; Gotoh N; Niwa T; Kikuchi Y; Tada K; Goshima N; Semba K; Inoue JI
    Cancer Sci; 2017 Jun; 108(6):1210-1222. PubMed ID: 28371195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. UBE2C, Directly Targeted by miR-548e-5p, Increases the Cellular Growth and Invasive Abilities of Cancer Cells Interacting with the EMT Marker Protein Zinc Finger E-box Binding Homeobox 1/2 in NSCLC.
    Jin D; Guo J; Wu Y; Du J; Wang X; An J; Hu B; Kong L; Di W; Wang W
    Theranostics; 2019; 9(7):2036-2055. PubMed ID: 31037155
    [No Abstract]   [Full Text] [Related]  

  • 5. BCL6 induces EMT by promoting the ZEB1-mediated transcription repression of E-cadherin in breast cancer cells.
    Yu JM; Sun W; Hua F; Xie J; Lin H; Zhou DD; Hu ZW
    Cancer Lett; 2015 Sep; 365(2):190-200. PubMed ID: 26049022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reciprocal regulation of ZEB1 and AR in triple negative breast cancer cells.
    Graham TR; Yacoub R; Taliaferro-Smith L; Osunkoya AO; Odero-Marah VA; Liu T; Kimbro KS; Sharma D; O'Regan RM
    Breast Cancer Res Treat; 2010 Aug; 123(1):139-47. PubMed ID: 19921427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pterostilbene inhibits triple-negative breast cancer metastasis via inducing microRNA-205 expression and negatively modulates epithelial-to-mesenchymal transition.
    Su CM; Lee WH; Wu AT; Lin YK; Wang LS; Wu CH; Yeh CT
    J Nutr Biochem; 2015 Jun; 26(6):675-85. PubMed ID: 25792283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 53BP1 suppresses epithelial-mesenchymal transition by downregulating ZEB1 through microRNA-200b/429 in breast cancer.
    Kong X; Ding X; Li X; Gao S; Yang Q
    Cancer Sci; 2015 Aug; 106(8):982-9. PubMed ID: 26011542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiation exposure triggers the progression of triple negative breast cancer via stabilizing ZEB1.
    Lin Y; Bai X; Zhou W; He Y; Wu Y; Wang X
    Biomed Pharmacother; 2018 Nov; 107():1624-1630. PubMed ID: 30257380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of epithelial-mesenchymal transition-related markers in triple-negative breast cancer: ZEB1 as a potential biomarker for poor clinical outcome.
    Jang MH; Kim HJ; Kim EJ; Chung YR; Park SY
    Hum Pathol; 2015 Sep; 46(9):1267-74. PubMed ID: 26170011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncogenic functions of the EMT-related transcription factor ZEB1 in breast cancer.
    Wu HT; Zhong HT; Li GW; Shen JX; Ye QQ; Zhang ML; Liu J
    J Transl Med; 2020 Feb; 18(1):51. PubMed ID: 32014049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ZEB1 Collaborates with ELK3 to Repress E-Cadherin Expression in Triple-Negative Breast Cancer Cells.
    Cho HJ; Oh N; Park JH; Kim KS; Kim HK; Lee E; Hwang S; Kim SJ; Park KS
    Mol Cancer Res; 2019 Nov; 17(11):2257-2266. PubMed ID: 31511359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MiR-652 inhibits acidic microenvironment-induced epithelial-mesenchymal transition of pancreatic cancer cells by targeting ZEB1.
    Deng S; Li X; Niu Y; Zhu S; Jin Y; Deng S; Chen J; Liu Y; He C; Yin T; Yang Z; Tao J; Xiong J; Wu H; Wang C; Zhao G
    Oncotarget; 2015 Nov; 6(37):39661-75. PubMed ID: 26498682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coordinated regulation of β-tubulin isotypes and epithelial-to-mesenchymal transition protein ZEB1 in breast cancer cells.
    Lobert S; Graichen ME; Morris K
    Biochemistry; 2013 Aug; 52(32):5482-90. PubMed ID: 23869586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct repression of MYB by ZEB1 suppresses proliferation and epithelial gene expression during epithelial-to-mesenchymal transition of breast cancer cells.
    Hugo HJ; Pereira L; Suryadinata R; Drabsch Y; Gonda TJ; Gunasinghe NP; Pinto C; Soo ET; van Denderen BJ; Hill P; Ramsay RG; Sarcevic B; Newgreen DF; Thompson EW
    Breast Cancer Res; 2013 Nov; 15(6):R113. PubMed ID: 24283570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The EMT-activator ZEB1 induces bone metastasis associated genes including BMP-inhibitors.
    Mock K; Preca BT; Brummer T; Brabletz S; Stemmler MP; Brabletz T
    Oncotarget; 2015 Jun; 6(16):14399-412. PubMed ID: 25973542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An hTERT/ZEB1 complex directly regulates E-cadherin to promote epithelial-to-mesenchymal transition (EMT) in colorectal cancer.
    Qin Y; Tang B; Hu CJ; Xiao YF; Xie R; Yong X; Wu YY; Dong H; Yang SM
    Oncotarget; 2016 Jan; 7(1):351-61. PubMed ID: 26540342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of MicroRNA-101 Promotes Epithelial to Mesenchymal Transition in Hepatocytes.
    Zhao S; Zhang Y; Zheng X; Tu X; Li H; Chen J; Zang Y; Zhang J
    J Cell Physiol; 2015 Nov; 230(11):2706-17. PubMed ID: 25808945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The ubiquitin ligase Siah is a novel regulator of Zeb1 in breast cancer.
    Chen A; Wong CS; Liu MC; House CM; Sceneay J; Bowtell DD; Thompson EW; Möller A
    Oncotarget; 2015 Jan; 6(2):862-73. PubMed ID: 25528765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The deubiquitinase BRCC3 increases the stability of ZEB1 and promotes the proliferation and metastasis of triple-negative breast cancer cells.
    Huang Q; Zheng S; Gu H; Yang Z; Lu Y; Yu X; Guo G
    Acta Biochim Biophys Sin (Shanghai); 2024 Apr; 56(4):564-575. PubMed ID: 38449391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.